These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34007531)

  • 1. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
    So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J
    Innov Pharm; 2019; 10(1):. PubMed ID: 34007531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility.
    Kielly J; Kelly DV; Hughes C; Day K; Hancock S; Asghari S; Gahagan J; Marra C; Nguyen H
    Pilot Feasibility Stud; 2018; 4():59. PubMed ID: 30788134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
    Januszka J; Notarianni V; Devenny E; Harris E
    J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Community Pharmacists' Perception on Readiness to Initiate Point-of-Care Testing for SARS-CoV-2 in New York State During the Pandemic.
    Ngwu RO; Lindeau R; Bielecki LM; Daly CJ
    J Pharm Pract; 2024 Apr; 37(2):324-334. PubMed ID: 36242519
    [No Abstract]   [Full Text] [Related]  

  • 6. A state-level needs analysis of community pharmacy point-of-care testing.
    Gallimore CE; Porter AL; Barnett SG; Portillo E; Zorek JA
    J Am Pharm Assoc (2003); 2021; 61(3):e93-e98. PubMed ID: 33431252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies.
    McKeirnan K; Kherghehpoush S; Gladchuk A; Patterson S
    Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33923668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of community pharmacies in the HIV and HCV care continuum.
    Kherghehpoush S; McKeirnan KC
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100215. PubMed ID: 36938123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
    Min AC; Andres JL; Grover AB; Megherea O
    Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement.
    Hohmeier KC; McKeirnan K; Akers J; Klepser M; Klepser SA; Chen C; Klepser DG
    Implement Sci Commun; 2022 Jul; 3(1):77. PubMed ID: 35842688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Training student pharmacists to facilitate human immunodeficiency virus point-of-care testing.
    Staudt AM; Draime JA; Deitschmann N; Norfolk M; Jenkins ZN
    Curr Pharm Teach Learn; 2020 Oct; 12(10):1245-1251. PubMed ID: 32739062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacist workflow and medication therapy management delegation: An assessment of preferences and barriers.
    Hohmeier KC; Wheeler J; Heintz K; Gatwood J
    J Am Pharm Assoc (2003); 2020; 60(6):e215-e223. PubMed ID: 32811750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing point-of-care testing through standardized training and redeployment of pharmacy technicians in the community setting.
    Pope S; Hill H; Cardosi L; Henson L; Wasson M; Stallworth S; Ward K; Desselle SP; Hohmeier KC
    Explor Res Clin Soc Pharm; 2021 Jun; 2():100034. PubMed ID: 35481116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
    Dong BJ; Lopez M; Cocohoba J
    J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.